-
1
-
-
77957255815
-
Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ
-
Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 3762-3769
-
-
Rudloff, U.1
Jacks, L.M.2
Goldberg, J.I.3
-
2
-
-
70350092772
-
NCCN task force report: Estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry
-
suppl 6
-
Allred DC, Carlson RW, Berry DA, et al: NCCN task force report: Estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw 7:S1-S23, 2009 (suppl 6)
-
(2009)
J Natl Compr Canc Netw
, vol.7
-
-
Allred, D.C.1
Carlson, R.W.2
Berry, D.A.3
-
3
-
-
77954526150
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
-
Hammond ME, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 2784-2795
-
-
Hammond, M.E.1
Hayes, D.F.2
Dowsett, M.3
-
5
-
-
0027994342
-
Mammographically-detected ductal in situ carcinoma of the breast analysed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity
-
Zafrani B, Leroyer A, Fourquet A, et al: Mammographically-detected ductal in situ carcinoma of the breast analysed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol 11:208-214, 1994
-
(1994)
Semin Diagn Pathol
, vol.11
, pp. 208-214
-
-
Zafrani, B.1
Leroyer, A.2
Fourquet, A.3
-
6
-
-
0030757825
-
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast
-
Holland PA, Knox WF, Potten CS, et al: Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst 89:1059-1065, 1997 (Pubitemid 27327871)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, Issue.14
, pp. 1059-1065
-
-
Holland, P.A.1
Knox, W.F.2
Potten, C.S.3
Howell, A.4
Anderson, E.5
Baildam, A.D.6
Bundred, N.J.7
-
7
-
-
0030037187
-
Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: Correlation with morphological features and recently proposed schemes for histological classification
-
DOI 10.1016/S0960-9776(96)90054-5
-
Millis RR, Bobrow LG, Barnes DM: Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: Correlation with morphological features and recently proposed schemes for histological classification. Breast 5:113-122, 1996 (Pubitemid 26234097)
-
(1996)
Breast
, vol.5
, Issue.3
, pp. 113-122
-
-
Millis, R.R.1
Bobrow, L.G.2
Barnes, D.M.3
-
8
-
-
0028931870
-
Loss of heterozygosity in ductal carcinoma in situ of the breast
-
Stratton MR, Collins N, Lakhani SR, et al: Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175:195-201, 1995
-
(1995)
J Pathol
, vol.175
, pp. 195-201
-
-
Stratton, M.R.1
Collins, N.2
Lakhani, S.R.3
-
9
-
-
0032490119
-
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci
-
O'Connell P, Pekkel V, Fuqua SA, et al: Analysis of loss of heterozygosity in 399 premalignant breast cancer lesions at 15 genetic loci. J Natl Cancer Inst 90:697-703, 1998 (Pubitemid 28222144)
-
(1998)
Journal of the National Cancer Institute
, vol.90
, Issue.9
, pp. 697-703
-
-
O'Connell, P.1
Pekkel, V.2
Fuqua, S.A.W.3
Osborne, C.K.4
Clark, G.M.5
Allred, D.C.6
-
10
-
-
77952054026
-
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
-
Kerlikowske K, Molinaro AM, Gauthier ML, et al: Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102:627-637, 2010
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 627-637
-
-
Kerlikowske, K.1
Molinaro, A.M.2
Gauthier, M.L.3
-
11
-
-
0034930801
-
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
-
DOI 10.1053/ejso.2000.1062
-
Bijker N, Rutgers EJ, Peterse JL, et al: Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 27:135-140, 2001 (Pubitemid 32621723)
-
(2001)
European Journal of Surgical Oncology
, vol.27
, Issue.2
, pp. 135-140
-
-
Bijker, N.1
Rutgers, E.J.T.2
Peterse, J.L.3
Fentiman, I.S.4
Julien, J.-P.5
Duchateau, L.6
Van, D.J.A.7
-
12
-
-
0031888111
-
Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast
-
American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology
-
Winchester DP, Strom EA: Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology CA Cancer J Clin 48:108-128, 1998
-
(1998)
CA Cancer J Clin
, vol.48
, pp. 108-128
-
-
Winchester, D.P.1
Strom, E.A.2
-
13
-
-
0033744928
-
Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted?
-
Lee CH, Carter D, Philpotts LE, et al: Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted? Radiology 217:466-470, 2000
-
(2000)
Radiology
, vol.217
, pp. 466-470
-
-
Lee, C.H.1
Carter, D.2
Philpotts, L.E.3
|